BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30664212)

  • 1. Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
    Ma R; Xu Y; Zhou H; Zhang D; Yao D; Song L; Liu Y
    Mol Med Rep; 2019 Mar; 19(3):2421-2430. PubMed ID: 30664212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
    Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
    Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
    Ma R; Liu L; Jiang W; Yu Y; Song H
    Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.
    Schlöndorff J; Del Camino D; Carrasquillo R; Lacey V; Pollak MR
    Am J Physiol Cell Physiol; 2009 Mar; 296(3):C558-69. PubMed ID: 19129465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L; Jirka G; Rosenberg PB; Buckley AF; Gomez JA; Fields TA; Winn MP; Spurney RF
    J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Role of Tangshen Formula on the Progression of Renal Damage in
    Wang Q; Tian X; Zhou W; Wang Y; Zhao H; Li J; Zhou X; Zhang H; Zhao T; Li P
    J Diabetes Res; 2020; 2020():3634974. PubMed ID: 33015191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
    Wang Y; Jarad G; Tripathi P; Pan M; Cunningham J; Martin DR; Liapis H; Miner JH; Chen F
    J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.
    Reiser J; Polu KR; Möller CC; Kenlan P; Altintas MM; Wei C; Faul C; Herbert S; Villegas I; Avila-Casado C; McGee M; Sugimoto H; Brown D; Kalluri R; Mundel P; Smith PL; Clapham DE; Pollak MR
    Nat Genet; 2005 Jul; 37(7):739-44. PubMed ID: 15924139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway.
    Zhang S; Wang H; Liu Y; Yang W; Liu J; Han Y; Liu Y; Liu F; Sun L; Xiao L
    J Cell Mol Med; 2020 Sep; 24(17):9810-9824. PubMed ID: 32779844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
    Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
    J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrimental effects of hypoxia on glomerular podocytes.
    Singh AK; Kolligundla LP; Francis J; Pasupulati AK
    J Physiol Biochem; 2021 May; 77(2):193-203. PubMed ID: 33835424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members.
    Zhao Y; Wu J; Zhang M; Zhou M; Xu F; Zhu X; Zhou X; Lang Y; Yang F; Yun S; Shi S; Liu Z
    J Mol Med (Berl); 2017 Aug; 95(8):887-898. PubMed ID: 28540409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.
    Yu J; Zhu C; Yin J; Yu D; Wan F; Tang X; Jiang X
    Drug Des Devel Ther; 2020; 14():361-370. PubMed ID: 32095070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
    PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.